{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:34:54Z","timestamp":1783953294134,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.neuropharm.2020.107996","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T13:36:42Z","timestamp":1581428202000},"page":"107996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Learned avoidance requires VTA KOR-mediated reductions in dopamine"],"prefix":"10.1016","volume":"167","author":[{"given":"Mykel A.","family":"Robble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Bozsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuropharm.2020.107996_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tins.2006.12.003","article-title":"Space, time and dopamine","volume":"30","author":"Arbuthnott","year":"2007","journal-title":"Trends Neurosci."},{"issue":"45","key":"10.1016\/j.neuropharm.2020.107996_bib2","doi-asserted-by":"crossref","first-page":"15779","DOI":"10.1523\/JNEUROSCI.3557-12.2012","article-title":"Aversive stimuli differentially modulate real-time dopamine transmission dynamics within the nucleus accumbens core and shell","volume":"32","author":"Badrinarayan","year":"2012","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2020.107996_bib3","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.celrep.2017.01.030","article-title":"Projection-target-defined effects of orexin and dynorphin on VTA dopamine neurons","volume":"18","author":"Baimel","year":"2017","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.107996_bib4","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1152\/jn.01140.2006","article-title":"Statistics of midbrain dopamine neuron spike trains in the awake primate","volume":"98","author":"Bayer","year":"2007","journal-title":"J. Neurophysiol."},{"issue":"22","key":"10.1016\/j.neuropharm.2020.107996_bib5","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1523\/JNEUROSCI.1039-08.2008","article-title":"Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol","volume":"28","author":"Bertran-Gonzalez","year":"2008","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2020.107996_bib6","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1523\/JNEUROSCI.4275-07.2008","article-title":"Presynaptic opioid and nicotine receptor modulation of dopamine overflow in the nucleus accumbens","volume":"28","author":"Britt","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.107996_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1037\/0022-3514.67.2.319","article-title":"Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: the BIS\/BAS scales","volume":"67","author":"Carver","year":"1994","journal-title":"J. Pers. Soc. Psychol."},{"key":"10.1016\/j.neuropharm.2020.107996_bib8","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1038\/npp.2013.171","article-title":"Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion","volume":"38","author":"Chefer","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2020.107996_bib9","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1523\/JNEUROSCI.4467-08.2009","article-title":"Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration","volume":"29","author":"Cools","year":"2009","journal-title":"J. Neurosci."},{"issue":"17","key":"10.1016\/j.neuropharm.2020.107996_bib10","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1073\/pnas.1404323111","article-title":"Aversive behavior induced by optogenetic inactivation of ventral tegmental area dopamine neurons is mediated by dopamine D2 receptors in the nucleus accumbens","volume":"111","author":"Danjo","year":"2014","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.107996_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuron.2018.11.005","article-title":"A neural circuit mechanism for encoding aversive stimuli in the mesolimbic dopamine system","volume":"101","author":"de Jong","year":"2019","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.107996_bib12","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/npp.2008.175","article-title":"Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers","volume":"34","author":"de Ruiter","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"42","key":"10.1016\/j.neuropharm.2020.107996_bib13","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1523\/JNEUROSCI.1894-10.2010","article-title":"Influence of phasic and tonic dopamine release on receptor activation","volume":"30","author":"Dreyer","year":"2010","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.107996_bib59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1152\/jn.00502.2012","article-title":"Mathematical model of dopamine autoreceptors and uptake inhibitors and their influence on tonic and phasic dopamine signaling","volume":"109","author":"Dreyer","year":"2013","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.107996_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-010-1836-5","article-title":"Depressive-like effects of kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens","volume":"210","author":"Ebner","year":"2010","journal-title":"Psychopharmacology"},{"issue":"37","key":"10.1016\/j.neuropharm.2020.107996_bib15","doi-asserted-by":"crossref","first-page":"12917","DOI":"10.1523\/JNEUROSCI.2444-15.2015","article-title":"Kappa opioid receptor-induced aversion requires p38 MAPK activation in VTA dopamine neurons","volume":"35","author":"Ehrich","year":"2015","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.107996_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biopsych.2009.02.024","article-title":"Decision making and executive function in male adolescents with early-onset or adolescence-onset conduct disorder and control subjects","volume":"66","author":"Fairchild","year":"2009","journal-title":"Biol. Psychiatr."},{"issue":"10","key":"10.1016\/j.neuropharm.2020.107996_bib17","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1523\/JNEUROSCI.4331-05.2006","article-title":"Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location","volume":"26","author":"Ford","year":"2006","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.107996_bib18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.biopsych.2014.07.021","article-title":"Nucleus accumbens medium spiny neuron subtypes mediate depression-related outcomes to social defeat stress","volume":"77","author":"Francis","year":"2015","journal-title":"Biol. Psychiatr."},{"issue":"5703","key":"10.1016\/j.neuropharm.2020.107996_bib19","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1126\/science.1102941","article-title":"By carrot or by stick: cognitive reinforcement learning in parkinsonism","volume":"306","author":"Frank","year":"2004","journal-title":"Science"},{"issue":"4986","key":"10.1016\/j.neuropharm.2020.107996_bib20","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.107996_bib21","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.neuron.2012.12.034","article-title":"Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity","volume":"77","author":"Graziane","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.107996_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(78)90568-1","article-title":"The taste reactivity test. 1. Mimetic responses to gustatory stimuli in neurologically normal rats","volume":"143","author":"Grill","year":"1978","journal-title":"Brain Res."},{"issue":"19","key":"10.1016\/j.neuropharm.2020.107996_bib23","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1021\/ac0491509","article-title":"Resolving neurotransmitters detected by fast-scan cyclic voltammetry","volume":"76","author":"Heien","year":"2004","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.107996_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1073\/pnas.1220358110","article-title":"Pathway-specific modulation of nucleus accumbens in reward and aversive behavior via selective transmitter receptors","volume":"110","author":"Hikida","year":"2013","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"6","key":"10.1016\/j.neuropharm.2020.107996_bib25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nn.3100","article-title":"Distinct roles for direct and indirect pathway striatal neurons in reinforcement","volume":"15","author":"Kravitz","year":"2012","journal-title":"Nat. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2020.107996_bib26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0006-3223(02)01369-0","article-title":"Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects","volume":"52","author":"Laakso","year":"2002","journal-title":"Biol. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.107996_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin \u03ba-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J. Neurosci."},{"issue":"6002","key":"10.1016\/j.neuropharm.2020.107996_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1188472","article-title":"Cell type\u2013specific loss of BDNF signaling mimics optogenetic control of cocaine reward","volume":"330","author":"Lobo","year":"2010","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.neuropharm.2020.107996_bib29","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1469-7610.2008.01910.x","article-title":"Decision\u2010making in ADHD: sensitive to frequency but blind to the magnitude of penalty?","volume":"49","author":"Luman","year":"2008","journal-title":"JCPP (J. Child Psychol. Psychiatry)"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.107996_bib30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cne.903500307","article-title":"Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study","volume":"350","author":"Mansour","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107996_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.biopsych.2012.07.007","article-title":"Context-induced relapse to alcohol seeking after punishment in a rat model","volume":"73","author":"Marchant","year":"2013","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.107996_bib32","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1152\/jn.00855.2004","article-title":"Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons","volume":"93","author":"Margolis","year":"2005","journal-title":"J. Neurophysiol."},{"issue":"8","key":"10.1016\/j.neuropharm.2020.107996_bib33","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1073\/pnas.0511159103","article-title":"\u03ba opioids selectively control dopaminergic neurons projecting to the prefrontal cortex","volume":"103","author":"Margolis","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2020.107996_bib34","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2020.107996_bib35","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/s41593-018-0222-1","article-title":"Dopamine neurons projecting to the posterior striatum reinforce avoidance of threatening stimuli","volume":"21","author":"Menegas","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"16","key":"10.1016\/j.neuropharm.2020.107996_bib36","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1073\/pnas.1315542111","article-title":"Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in the ventral tegmental area","volume":"111","author":"Muschamp","year":"2014","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.107996_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1471-4159.2012.07677.x","article-title":"Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens","volume":"121","author":"Owesson-White","year":"2012","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.107996_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1471-4159.1992.tb09298.x","article-title":"Extracellular concentration and in vivo recovery of dopamine in the nucleus accumbens using microdialysis","volume":"58","author":"Parsons","year":"1992","journal-title":"J. Neurochem."},{"issue":"4765","key":"10.1016\/j.neuropharm.2020.107996_bib39","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.107996_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-8993(93)90693-H","article-title":"Cellular substrates for interactions between dynorphin dynorphin terminals and dopamine dendrites in the rat ventral tegmental area and substantia nigra","volume":"602","author":"Pickel","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.107996_bib41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2014.04.019","article-title":"Poststress block of kappa opioid receptors rescues long-term potentiation of inhibitory synapses and prevents reinstatement of cocaine seeking","volume":"76","author":"Polter","year":"2014","journal-title":"Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.neuropharm.2020.107996_bib42","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1111\/ejn.12253","article-title":"Development of behavioral preferences for the optimal choice following unexpected reward omission is mediated by a reduction of D2\u2010like receptor tone in the nucleus accumbens","volume":"38","author":"Porter-Stransky","year":"2013","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.107996_bib43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.brainresrev.2008.02.004","article-title":"Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway","volume":"58","author":"Rice","year":"2008","journal-title":"Brain Res. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.107996_bib44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0306-4522(89)90168-1","article-title":"Anatomical and affinity state comparisons between dopamine D 1 and D 2 receptors in the rat central nervous system","volume":"30","author":"Richfield","year":"1989","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.107996_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00213-010-1880-1","article-title":"Dopamine precursor depletion improves punishment prediction during reversal learning in healthy females but not males","volume":"11","author":"Robinson","year":"2010","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2020.107996_bib46","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/nn.2219","article-title":"Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli","volume":"11","author":"Roitman","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2020.107996_bib47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1101\/lm.1869710","article-title":"Hedonic and nucleus accumbens neural responses to a natural reward are regulated by aversive conditioning","volume":"17","author":"Roitman","year":"2010","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2020.107996_bib48","first-page":"563","article-title":"Differential effects of mu and kappa opioid systems on motivational processes","volume":"75","author":"Shippenberg","year":"1986","journal-title":"NIDA Res. Monogr."},{"issue":"19","key":"10.1016\/j.neuropharm.2020.107996_bib60","doi-asserted-by":"crossref","first-page":"6717","DOI":"10.1021\/ac0608218","article-title":"Monitoring dopamine in vivo by microdialysis sampling and on-line CE-laser-induced fluorescence","volume":"78","author":"Shou","year":"2006","journal-title":"Anal. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.107996_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.baga.2016.02.001","article-title":"Striatal dopamine neurotransmission: regulation of release and uptake","volume":"6","author":"Sulzer","year":"2016","journal-title":"Basal Ganglia"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.107996_bib50","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1073\/pnas.97.4.1856","article-title":"Regulation of the phosphorylation of the dopamine-and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors","volume":"97","author":"Svenningsson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"6","key":"10.1016\/j.neuropharm.2020.107996_bib51","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.neuron.2012.02.015","article-title":"GABA neurons of the VTA drive conditioned place aversion","volume":"73","author":"Tan","year":"2012","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.neuropharm.2020.107996_bib52","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.biopsych.2014.09.004","article-title":"Aversive stimuli drive drug seeking in a state of low dopamine tone","volume":"77","author":"Twining","year":"2015","journal-title":"Biol. Psychiatr."},{"issue":"5666","key":"10.1016\/j.neuropharm.2020.107996_bib62","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1126\/science.1093360","article-title":"Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli","volume":"303","author":"Ungless","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.107996_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-013-3195-5","article-title":"Role of kappa-opioid receptors in stress and anxiety-related behavior","volume":"229","author":"Van\u2019t Veer","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.107996_bib54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/35083500","article-title":"Dopamine responses comply with basic assumptions of formal learning theory","volume":"412","author":"Waelti","year":"2001","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.neuropharm.2020.107996_bib55","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.biopsych.2011.02.014","article-title":"Cocaine cues drive opposing context-dependent shifts in reward processing and emotional state","volume":"69","author":"Wheeler","year":"2011","journal-title":"Biol. Psychiatr."},{"issue":"18","key":"10.1016\/j.neuropharm.2020.107996_bib56","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.1523\/JNEUROSCI.4823-14.2015","article-title":"Drug predictive cues activate aversion-sensitive striatal neurons that encode drug seeking","volume":"35","author":"Wheeler","year":"2015","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2020.107996_bib58","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuron.2008.01.024","article-title":"Behavioral and electrophysiological indices of negative affect predict cocaine self-administration","volume":"57","author":"Wheeler","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.107996_bib61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-psych-010418-103337","article-title":"Dopamine and Addiction","volume":"71","author":"Wise","year":"2020","journal-title":"Annu. Rev. Psychol."},{"issue":"11","key":"10.1016\/j.neuropharm.2020.107996_bib57","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/nn.3813","article-title":"Visualizing an emotional valence map in the limbic forebrain by TAI-FISH","volume":"17","author":"Xiu","year":"2014","journal-title":"Nat. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:02:59Z","timestamp":1758438179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820300629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":62,"alternative-id":["S0028390820300629"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107996","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Learned avoidance requires VTA KOR-mediated reductions in dopamine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107996"}}